Replies to post #148738 on Cytodyn Inc (CYDY)

[Birddogfishman]

Thanks Hank,

When investing in any biotech, I always try to look at the worst case scenario, do my DD with a little gut feeling throw in. As I stated, even if the CD12 fails, there is still the HIV trial that has been completed and just needs the BLA filed and that is as close to a sure thing as any other biotech out there. I also thought about HGEN when the price was running parallel to CYDY post reverse split, but I kept getting a feeling of something not being right on that one, hope I am wrong, but I still get the feeling that things are not adding up. Their drug is a GM-CSF similar to the GSK drug that failed in trials and was only successful with patients over 70.